Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell

Xaira Therapeutics, an AI-driven drug development company launched in April 2024 with $1B in funding and a prestigious leadership team including Nobel laureates David Baker and Carolyn Bertozzi, has made a major scientific contribution in its first year. The company released X-Atlas/Orion, the largest publicly available Perturb-seq dataset, enabling large-scale analysis of how cells respond to external conditions like drug treatments.